Abiopharma

🔍 RHODES KEVIN R (Executive)

Company: EXTREME NETWORKS INC (EXTR)

Report Date: 2026-05-30

Detailed Transactions and Holdings:

• Acquired 11,860 shares of Common Stock (Direct)
  Date: 2026-05-30 | Code: M | equity_swap_involved: 0 | shares_owned_after: 163,045.00 | transaction_form_type: 4
• Sold 5,260 shares of Common Stock at $26.51 per share (Direct)
  Date: 2026-05-30 | Code: F | equity_swap_involved: 0 | shares_owned_after: 157,785.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 51,233 shares of Common Stock (Direct)
  Date: 2026-06-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 209,018.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 22,722 shares of Common Stock at $28.13 per share (Direct)
  Date: 2026-06-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 186,296.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 11,860 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-30 | Code: M | Expires: 2026-05-30 | Exercise: 2024-05-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents shares withheld from the released share award for the payment of applicable income and payroll withholding taxes due on release.
• F2: Represents shares of common stock issued to the Reporting Person pursuant to a performance award dated 05/30/2023. The number of shares earned was subject to attainment of certain performance conditions and certification thereof by the Compensation Committee, which certification occurred on 06/01/2026.
• F3: This Time-based RSU award vests from the original grant date as to 1/3 on the one year anniversary and 1/12 each quarter thereafter.